SCHEMBL10075780

SCHEMBL10075780

CC(=O)O/N=C(\C)C(=O)c1ccc(Sc2ccc(C(=O)OCC(O)c3ccccc3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 1/20 0.37
GAA P10253 1/20 0.36
ADRB2 P07550 4/20 0.36
ADRB1 P08588 4/20 0.36
ADRB3 P13945 4/20 0.36
SLC1A5 Q15758 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
BCAT2 O15382 1/20 0.33
MEN1 O00255 2/20 0.32
PRKCA P17252 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
CYP3A4 P08684 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10075792 0.87 ABCB1 (0.39) ALDH1A1KMT2AHPGDMAPTMEN1
SCHEMBL10075768 0.85 L3MBTL1 (0.41) ALDH1A1L3MBTL1KMT2AHPGDMAPT
SCHEMBL10075825 0.85 KMT2A (0.51) ALDH1A1L3MBTL1KMT2AMAPTADRB2
SCHEMBL10075797 0.85 KMT2A (0.36) ALDH1A1L3MBTL1KMT2AHPGDKDM4E
SCHEMBL20709769 0.84 NPC1 (0.43) ALDH1A1HPGDKDM4EMAPTHTT
SCHEMBL19795435 0.81 HPGD (0.56) ALDH1A1L3MBTL1KMT2AHPGDMAPT
SCHEMBL16019156 0.81 HPGD (0.56) ALDH1A1L3MBTL1KMT2AHPGDMAPT
SCHEMBL10075710 0.81 L3MBTL1 (0.45) ALDH1A1L3MBTL1KMT2AHPGDKDM4E
SCHEMBL10075827 0.80 MAPT (0.45) ALDH1A1L3MBTL1KMT2AHPGDKDM4E
SCHEMBL10075808 0.79 L3MBTL1 (0.41) ALDH1A1L3MBTL1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3438134-A1 POLYMERIZABLE COMPOSITION, CURED OBJECT, OPTICAL FILM FOR DISPLAY, AND PROCESS FOR PRODUCING CURED OBJECT Adeka Corporation (JP) 2019-02-06 EP disclosed
EP-2586827-B1 CURABLE RESIN COMPOSITION ADEKA CORP (JP) 2017-12-27 EP disclosed
US-8735511-B2 Curing resin composition ADEKA CORPORATION (JP) 2014-05-27 US disclosed
US-8735511-B2 Curing resin composition ADEKA CORPORATION (JP) 2014-05-27 US disclosed
EP-2586827-A1 CURABLE RESIN COMPOSITION Adeka Corporation (JP) 2013-05-01 EP disclosed
US-20120115972-A1 CURING RESIN COMPOSITION ADEKA CORPORATION (JP) 2012-05-10 US disclosed
US-20120115972-A1 CURING RESIN COMPOSITION ADEKA CORPORATION (JP) 2012-05-10 US disclosed
US-8148045-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2012-04-03 US disclosed
US-8148045-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2012-04-03 US disclosed
EP-2327689-B1 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORP (JP) 2012-02-29 EP disclosed
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-02 US disclosed
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2011-06-02 US disclosed
EP-2327689-A1 Oxime ester compound and photopolymerization initiator containing the same Adeka Corporation (JP) 2011-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110129778-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME OXER1, OR10J3, CDK11B ALDH1A1 2329/4885L3MBTL1 1628/4885KMT2A 3531/4885
US-20120115972-A1 CURING RESIN COMPOSITION LTA, LOXL1, PLOD2 ALDH1A1 203/4885L3MBTL1 228/4885KMT2A 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.